Skip to content
Gut Metabolic

Interactive tool · Strain lookup

Strain-to-Evidence Lookup

The Probiotic Strain Finder starts from a goal. This tool starts from a strain — one you read on a label, saw in an ad, or heard about — and shows exactly what the human evidence supports for it, with an honest grade, across all 16 strains in our roster.

Read before you use this

This is a general educational guide, not medical advice, and not a product recommendation. Probiotic effects are small, strain-specific, and individual — they are not drugs and do not replace diet, exercise, or prescribed treatment. The evidence below belongs to a specific strain at a specific dose, which is rarely the same as a product on a shelf. If you are immunocompromised, critically ill, pregnant, have a central line, or have a serious GI condition, probiotics can carry real risks — talk to a licensed clinician or registered dietitian before starting anything.

  • Akkermansia muciniphila (pasteurized, Muc₁₀₀₀₀₀)Modest
    • Blood sugar / metabolicModest

      A small 3-month RCT in overweight/insulin-resistant adults found pasteurized Akkermansia improved insulin sensitivity and some metabolic markers. One short, single trial.

      Read the evidence →
  • Bifidobacterium & Lactobacillus blendsModest
    • General gut healthModest

      Common, well-tolerated, broadly studied for general digestive comfort; benefits are individual and often subtle in people without symptoms.

      Read the evidence →
  • Bifidobacterium lactis B420Modest
    • Blood sugar / metabolicModest

      In a 6-month RCT, B420 modestly reduced body-fat mass versus placebo; metabolic read-throughs were secondary and smaller.

      Read the evidence →
    • Weight / body fatModest

      The best single-strain body-fat trial here: ~6 months of B420 modestly lowered fat mass and waist size versus placebo.

      Read the evidence →
  • Bifidobacterium lactis DN-173 010Moderate
    • Constipation / regularityModerate

      Studied as a fermented-milk product; improves transit time and stool frequency, especially in women, in several trials.

      Read the evidence →
  • Bifidobacterium lactis HN019Moderate
    • Constipation / regularityModerate

      Multiple RCTs show HN019 shortens whole-gut transit time and improves regularity — among the strongest strain-specific constipation data.

      Read the evidence →
    • Bloating / gasModest

      Best evidenced for speeding gut transit (constipation-type bloating); shortening transit can reduce the trapped-gas kind of bloat for some.

      Read the evidence →
  • Clostridium butyricum CBM588Thin
    • Blood sugar / metabolicThin

      A butyrate-producing strain with mechanistic and early human data relevant to metabolism; direct metabolic-endpoint RCTs in this context are limited.

      Read the evidence →
    • Bloating / gasThin

      A butyrate-maker studied mostly for GI-infection and antibiotic-related symptoms; bloating-specific human data is limited.

      Read the evidence →
  • Dietary fiber + fermented foods (first line)Moderate
    • General gut healthModerate

      Increasing fiber and fermented-food variety has the most consistent human evidence for a healthier, more diverse microbiome — stronger than any single supplement strain.

      Read the evidence →
  • Hafnia alvei HA4597Thin
    • Weight / body fatThin

      An “appetite” strain built on a ClpB / α-MSH mimicry mechanism, with one small weight-management RCT. Intriguing but early.

      Read the evidence →
  • Lactobacillus gasseri SBT2055Modest
    • Weight / body fatModest

      A 12-week RCT in adults with an obese tendency reported a small reduction in abdominal (visceral) fat that partly rebounded after stopping.

      Read the evidence →
  • Lactobacillus rhamnosus GGModerate
    • Post-antibiotic recoveryModerate

      One of the most-studied strains for reducing antibiotic-associated diarrhea, particularly in children; effect sizes are real but modest.

      Read the evidence →
  • Multi-strain blends (for GLP-1 GI upset)Thin
    • Bloating / gasThin

      Evidence that a probiotic eases GLP-1-related nausea or bloating is indirect; some people improve, others get more gas. Start low and judge by your own response.

      Read the evidence →
  • Multi-strain blends (meta-analytic)Modest
    • Blood sugar / metabolicModest

      Meta-analyzes of probiotics in type-2 diabetes show a small average drop in fasting glucose and HbA1c, but with high heterogeneity across strains and products.

      Read the evidence →
  • Probiotics in general (meta-analytic)Modest
    • Weight / body fatModest

      Pooled RCTs show a statistically real but tiny average effect on body weight and BMI — on the order of under a kilogram. Don’t expect a visible change.

      Read the evidence →
  • Saccharomyces boulardii (a beneficial yeast)Moderate
    • Post-antibiotic recoveryModerate

      Among the best-evidenced agents for preventing antibiotic-associated diarrhea in meta-analyzes. Note it is a yeast, not a bacterium, so antibiotics don’t kill it.

      Read the evidence →
  • Spore-based (Bacillus) probioticsThin
    • General gut healthThin

      Survive stomach acid well and are heavily marketed for gut health, but the human metabolic/general-health evidence is still early and thin.

      Read the evidence →
  • Whole-diet fiber + fermented foods (not a pill)Modest
    • Post-antibiotic recoveryModest

      Recovery of the broader community after antibiotics is driven mostly by dietary fiber, fermented foods, and time — a single probiotic won’t “reset” it.

      Read the evidence →

How to read the grades. Moderate = at least one solid randomized trial with a meaningful, replicated-direction result (still modest by drug standards). Modest = one or two small or short trials, or a noisy pooled signal. Thin = mostly mechanistic, animal, or early human data — a hypothesis, not a recommendation. A strain shows its strongest grade across the goals it is evidenced for; the per-goal grade underneath may be lower.

How this is built

Every strain, evidence note, grade, and citation link here is drawn from the same goal-by-goal mapping behind the Probiotic Strain Finder — this tool only re-indexes it by strain name instead of by goal, so a strain evidenced under more than one goal (weight and blood sugar, for example) shows every goal-scoped note rather than being flattened into one. Grades stay deliberately conservative: Moderate means at least one solid randomized trial with a meaningful result (still modest by drug standards), Modest means one or two small trials or noisy pooled data, and Thin means mostly mechanism or early data. Most probiotic claims land at Modest or Thin, and we would rather say so than oversell.

This tool is informational and not medical advice. It summarizes published human evidence at a population level and cannot account for your individual health, medications, immune status, or GI conditions. Probiotics are not a treatment for any disease. Talk to a licensed clinician or registered dietitian before starting, stopping, or changing any supplement.